Found: 13
Select item for more details and to access through your institution.
HSPB1 rs2070804 polymorphism is associated with the depth of primary tumor.
- Published in:
- Journal of Cellular Biochemistry, 2020, v. 121, n. 1, p. 63, doi. 10.1002/jcb.28266
- By:
- Publication type:
- Article
Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210274
- By:
- Publication type:
- Article
Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0189582
- By:
- Publication type:
- Article
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway.
- Published in:
- International Journal of Medical Sciences, 2022, v. 19, n. 1, p. 34, doi. 10.7150/ijms.64850
- By:
- Publication type:
- Article
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10951, doi. 10.3390/ijms241310951
- By:
- Publication type:
- Article
PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10008, doi. 10.3390/ijms241210008
- By:
- Publication type:
- Article
The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0298154
- By:
- Publication type:
- Article
Cytotoxic properties of unfractionated and fractionated bromelain alone or in combination with chemotherapeutic agents in colorectal cancer cells.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0285970
- By:
- Publication type:
- Article
Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/4569718
- By:
- Publication type:
- Article
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180616
- By:
- Publication type:
- Article
2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 1798, doi. 10.3390/biomedicines11071798
- By:
- Publication type:
- Article
Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0211968
- By:
- Publication type:
- Article
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04363-5
- By:
- Publication type:
- Article